Roth Mkm Issues Pessimistic Forecast for Aspen Aerogels (NYSE:ASPN) Stock Price

Aspen Aerogels (NYSE:ASPN) had its price target cut by analysts at Roth Mkm from $36.00 to $31.00 in a research report issued on Friday,Benzinga reports. The firm presently has a “buy” rating on the construction company’s stock. Roth Mkm’s price objective would indicate a potential upside of 93.51% from the stock’s previous close.

ASPN has been the topic of several other research reports. HC Wainwright reaffirmed a “buy” rating and set a $30.00 price target on shares of Aspen Aerogels in a research report on Wednesday, October 16th. StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a research report on Thursday, October 31st. TD Cowen increased their price target on shares of Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research report on Tuesday, August 20th. Barclays initiated coverage on shares of Aspen Aerogels in a research report on Tuesday, August 6th. They set an “overweight” rating and a $27.00 price target on the stock. Finally, Piper Sandler reduced their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $28.90.

Aspen Aerogels Stock Down 4.5 %

NYSE:ASPN traded down $0.75 on Friday, reaching $16.02. The stock had a trading volume of 2,206,534 shares, compared to its average volume of 1,560,876. The company has a current ratio of 3.46, a quick ratio of 2.82 and a debt-to-equity ratio of 0.23. The company has a 50-day moving average of $23.35 and a 200 day moving average of $24.61. The stock has a market cap of $1.23 billion, a P/E ratio of -1,596.40 and a beta of 2.21. Aspen Aerogels has a 12-month low of $8.76 and a 12-month high of $33.15.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Wednesday, August 7th. The construction company reported $0.21 earnings per share for the quarter, beating analysts’ consensus estimates of $0.05 by $0.16. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The company had revenue of $117.80 million during the quarter, compared to analysts’ expectations of $101.99 million. During the same period in the prior year, the company posted ($0.22) EPS. The firm’s revenue for the quarter was up 144.4% on a year-over-year basis. On average, research analysts predict that Aspen Aerogels will post 0.1 earnings per share for the current year.

Insider Buying and Selling

In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the sale, the chief executive officer now owns 483,640 shares in the company, valued at approximately $14,523,709.20. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the sale, the chief executive officer now owns 483,640 shares in the company, valued at approximately $14,523,709.20. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the sale, the chief financial officer now owns 20,790 shares in the company, valued at $626,610.60. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Oppenheimer & Co. Inc. bought a new position in shares of Aspen Aerogels in the first quarter valued at approximately $388,000. Dakota Wealth Management bought a new position in shares of Aspen Aerogels in the third quarter valued at approximately $986,000. Rice Hall James & Associates LLC boosted its holdings in shares of Aspen Aerogels by 19.9% in the third quarter. Rice Hall James & Associates LLC now owns 535,113 shares of the construction company’s stock valued at $14,817,000 after acquiring an additional 88,711 shares in the last quarter. Comerica Bank bought a new stake in Aspen Aerogels during the first quarter worth approximately $1,992,000. Finally, Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in Aspen Aerogels by 66.7% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 80,591 shares of the construction company’s stock worth $1,922,000 after buying an additional 32,243 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.